Other
there was no intervention
there was no intervention is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
PHENOTYPE. Therapeutic Study in Barcelona
NCT02624921
completed
Scleral Response to Intraocular Pressure (IOP)
NCT03267862
completed
The Nutrition Care in Canadian Hospitals Study; 2010-2013.
NCT02351661
completed
Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Rhythm
NCT00772421
Clinical Trials (4)
Showing 4 of 4 trials
NCT02624921
PHENOTYPE. Therapeutic Study in Barcelona
NCT03267862
Scleral Response to Intraocular Pressure (IOP)
NCT02351661
The Nutrition Care in Canadian Hospitals Study; 2010-2013.
NCT00772421
Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Rhythm
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4